C. Wyrick

发表

Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.

J. Cadet, F. Carroll, A. Lewin, 1995, Molecular pharmacology.

Tritiation of SR141716 by metallation–iodination–reduction: tritium‐proton nOe study

F. Carroll, H. Seltzman, C. Wyrick, 2002 .

Synthesis, spectral studies and tritiation of the cannabinoid antagonist SR141716A

F. Carroll, H. Seltzman, C. Wyrick, 1995 .

Tritiation of the cannabinoid receptor antagonist SR144528 involving lithium aluminum tritide reduction; assessment of the kinetic isotope effect by 3H‐NMR

F. Carroll, H. Seltzman, C. Wyrick, 2005 .

Synthesis of nona-deutero olivetol and nona-deutero cannabinoids

H. Seltzman, C. Wyrick, M. K. Begum, 1991 .

Correlation of structure and transannular interactions in a series of cage compounds

W. Maier, P. Schleyer, William F. Smith, 1979 .

Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21)

M. Kuhar, F. Carroll, B. Thomas, 1996 .

Metallation/reduction as a new approach to tritium labeling. The synthesis of [3H]ibogaine

F. Carroll, C. Laudeman, H. Seltzman, 1994 .

A new approach to tritium labelling; the synthesis of [3H]ibogaine

F. Carroll, C. Wyrick, D. F. Odear, 1992 .

Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI‐121

F I Carroll, P Abraham, D. Mash, 1995, Synapse.

Protection of the allylic alcohol double bond from catalytic reduction in the preparation of [1‐3H]morphine and [1‐3H]codeine

F. Carroll, C. Laudeman, M. Roche, 1998 .